Screening for hepatitis infectivity among blood donors. A model for blood safety?
The safety of blood and blood products is based on three interdependent activities: selection of safe donors, laboratory testing, and, where applicable, treatment of the product to reduce residual infectivity. Posttransfusion hepatitis has provided both the initial stimulus and the model for these procedures. The procedures have resulted in a progressive increase in the safety of the blood supply, which is continuing, as evidenced by a 50% decrease in the frequency of reported posttransfusion hepatitis over the past two years.
Dodd
R Y
RY
Transmissible Diseases Laboratory, American Red Cross, Jerome H. Holland Laboratory, Rockville, Md.
D001771:Blood Banks; D001782:Blood Donors; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006525:Hepatitis, Viral, Human / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D012449:Safety; D065227:Transfusion Reaction
D006514:Hepatitis B Surface Antigens